Editorial
Copyright ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Surg Proced. May 21, 2019; 9(1): 7-11
Published online May 21, 2019. doi: 10.5412/wjsp.v9.i1.7
Can hyperthermic intraperitoneal chemotherapy effectively control gastric cancer-associated peritoneal carcinomatosis?
Chong-Chi Chiu, Chao-Jung Tsao, Jhi-Joung Wang, Yutaka Yonemura
Chong-Chi Chiu, Department of General Surgery, Chi Mei Medical Center, Liouying 73657 and Tainan 71004, Taiwan
Chong-Chi Chiu, Department of Electrical Engineering, Southern Taiwan University of Science and Technology, Tainan 71005, Taiwan
Chao-Jung Tsao, Department of Oncology, Chi Mei Medical Center, Liouying 73657, Taiwan
Jhi-Joung Wang, Department of Medical Research, Chi Mei Medical Center, Tainan 71004, Taiwan
Jhi-Joung Wang, AI Biomed Center, Southern Taiwan University of Science and Technology, Tainan 71005, Taiwan
Yutaka Yonemura, Peritoneal Surface Malignancy Center, Kishiwada Tokushukai Hospital, Kishiwada, Osaka 596-8522, Japan
Author contributions: All authors participated in the writing and editing of the manuscript.
Supported by grant from Chi Mei Medical Center, Liouying, Taiwan, No. CLFHR10606.
Conflict-of-interest statement: All authors declare no competing financial interests.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Yutaka Yonemura, PhD, Surgeon, Peritoneal Surface Malignancy Center, Kishiwada Tokushukai Hospital, 4-27-1 Kamori-Cho, Kishiwada, Osaka 596-8522, Japan. y.yonemura@coda.ocn.ne.jp
Telephone: +81-072-4459915
Received: December 25, 2018
Peer-review started: December 25, 2018
First decision: March 5, 2019
Revised: March 11, 2019
Accepted: April 19, 2019
Article in press: April 19, 2019
Published online: May 21, 2019
Processing time: 147 Days and 16.1 Hours
Core Tip

Core tip: Peritoneal carcinomatosis associated with gastric cancer leads to poor clinical outcomes and low quality of life. Hyperthermic intraperitoneal chemotherapy can potentially be used for the control of this disease.